Clinical Trial Update: Afatinib in Advanced NRG1-Rearranged Malignancies [Phase 2]

View source ↗

Summary

Phase 2 trial update of afatinib in metastatic and locally advanced NRG1-rearranged malignancies.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer
• Nrg1-rearranged Malignancies

Drugs mentioned

• Afatinib (afatinib)

Snippet

Sponsor: German Cancer Research Center | Conditions: Metastatic and Locally Advanced NRG1-rearranged Malignancies | Phase 2 | Status: COMPLETED